Literature DB >> 16567009

Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.

Jason R Clark1, John B March.   

Abstract

In recent years it has been recognized that bacteriophages have several potential applications in the modern biotechnology industry: they have been proposed as delivery vehicles for protein and DNA vaccines; as gene therapy delivery vehicles; as alternatives to antibiotics; for the detection of pathogenic bacteria; and as tools for screening libraries of proteins, peptides or antibodies. This diversity, and the ease of their manipulation and production, means that they have potential uses in research, therapeutics and manufacturing in both the biotechnology and medical fields. It is hoped that the wide range of scientists, clinicians and biotechnologists currently researching or putting phages to practical use are able to pool their knowledge and expertise and thereby accelerate progress towards further development in this exciting field of biotechnology.

Mesh:

Substances:

Year:  2006        PMID: 16567009     DOI: 10.1016/j.tibtech.2006.03.003

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  81 in total

1.  Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain.

Authors:  S B Santos; E Fernandes; C M Carvalho; S Sillankorva; V N Krylov; E A Pleteneva; O V Shaburova; A Nicolau; E C Ferreira; J Azeredo
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

2.  Evidence for the presence of Legionella bacteriophages in environmental water samples.

Authors:  Elke Lammertyn; Johan Vande Voorde; Eef Meyen; Liesbeth Maes; Jan Mast; Jozef Anné
Journal:  Microb Ecol       Date:  2007-10-24       Impact factor: 4.552

3.  Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms.

Authors:  R Briandet; P Lacroix-Gueu; M Renault; S Lecart; T Meylheuc; E Bidnenko; K Steenkeste; M-N Bellon-Fontaine; M-P Fontaine-Aupart
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

Review 4.  The art of engineering viral nanoparticles.

Authors:  Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

5.  PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.

Authors:  Kristofer J Christakos; Janice A Chapman; Bentley A Fane; Samuel K Campos
Journal:  Virology       Date:  2015-12-03       Impact factor: 3.616

6.  Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions.

Authors:  Joanna M Loś; Piotr Golec; Grzegorz Wegrzyn; Alicja Wegrzyn; Marcin Loś
Journal:  Appl Environ Microbiol       Date:  2008-06-27       Impact factor: 4.792

Review 7.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

8.  Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment.

Authors:  Pilar García; Beatriz Martínez; José María Obeso; Rob Lavigne; Rudi Lurz; Ana Rodríguez
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

9.  Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses.

Authors:  Giovanna Del Pozzo; Dina Mascolo; Rossella Sartorius; Alessandra Citro; Pasquale Barba; Luciana D'Apice; Piergiuseppe De Berardinis
Journal:  J Biomed Biotechnol       Date:  2010-04-29

10.  Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections.

Authors:  Shakeeba Waseh; Pejman Hanifi-Moghaddam; Russell Coleman; Michael Masotti; Shannon Ryan; Mary Foss; Roger MacKenzie; Matthew Henry; Christine M Szymanski; Jamshid Tanha
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.